Fidelity National Information Services Free cash flow decreased by 10.3% to $663.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 57.9%, from $420.00M to $663.00M. Over 4 years (FY 2021 to FY 2025), Free cash flow shows a downward trend with a -14.0% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
An increase suggests improved operational efficiency or reduced capital intensity, providing more flexibility for capital allocation. A decrease may indicate higher investment in R&D or infrastructure, or potential challenges in converting earnings into cash.
Free cash flow represents the cash generated by a company after accounting for cash outflows to support operations and m...
Large-cap medical device and pharmaceutical peers typically maintain strong, positive free cash flow, though levels vary based on the intensity of R&D spending and the lifecycle stage of major product lines.
free_cash_flow| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $954.00M | $1.78B | $986.00M | $788.00M | $959.00M | $835.00M | $1.13B | $593.00M | $1.06B | $1.07B | $1.50B | $179.00M | $530.00M | $605.00M | $764.00M | $420.00M | $343.00M | $952.00M | $739.00M | $663.00M |
| QoQ Change | — | +86.9% | -44.7% | -20.1% | +21.7% | -12.9% | +35.3% | -47.5% | +78.8% | +0.8% | +40.1% | -88.1% | +196.1% | +14.2% | +26.3% | -45.0% | -18.3% | +177.6% | -22.4% | -10.3% |
| YoY Change | — | — | — | — | +0.5% | -53.2% | +14.6% | -24.7% | +10.5% | +28.0% | +32.6% | -69.8% | -50.0% | -43.4% | -49.0% | +134.6% | -35.3% | +57.4% | -3.3% | +57.9% |